ORIC
Oric Pharmaceuticals Inc
13.30$
-1.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.2% | +37.7% | -6.2% | -8.2% | -9.2% | -11.4% | +42.8% | +24.3% | -4.7% | +6.3% | -7.3% | |
| – | -8.5% | +52.4% | -9.1% | -5.1% | -6.1% | -19.4% | +37.7% | +1.5% | -2.4% | +0.6% | -5.7% | |
| – | -10.9% | +141.0% | -11.6% | -11.2% | +34.3% | -17.0% | +53.8% | -34.5% | -8.1% | +23.5% | -33.5% | |
| – | -8.4% | +52.2% | -9.6% | -4.9% | -6.0% | -20.4% | +38.7% | +1.6% | -2.0% | +0.2% | -6.1% | |
| – | +13.7% | -27.6% | +19.7% | +5.9% | +10.5% | -25.5% | -1.1% | +6.2% | +9.8% | -20.4% | +10.5% | |
| – | +8.0% | -25.7% | +28.5% | +8.7% | +16.9% | -29.1% | +2.5% | +11.8% | +1.2% | -13.0% | +16.8% | |
| – | +0.9% | +0.8% | -0.2% | +12.7% | +2.0% | +0.9% | +1.9% | +0.9% | +0.9% | -1.0% | +0.9% | |
| – | -74.7% | +216.5% | -22.7% | +84.0% | -63.6% | +233.3% | -39.3% | -7.3% | +31.9% | -24.3% | +33.8% | |
| – | -9.4% | +46.7% | -8.0% | -9.4% | -11.3% | -9.6% | +47.4% | +25.6% | -5.5% | +8.1% | -8.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +17.2% | +4.5% | +0.3% | +0.2% | +0.5% | +10.0% | +26.7% | -11.3% | +20.1% | +2.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.